Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Pre Market
Current status date:
2021-07-29
Original market date: See footnote 1
Product name:
TEVA-ARSENIC TRIOXIDE FOR INJECTION
DIN:
02484358
Product Monograph/Veterinary Labelling:
Date:
2019-01-02
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada
M1B 2K9
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
10:00.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
L01XX27 ARSENIC TRIOXIDE
Active ingredient group (AIG) number:See footnote5
0108756003
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| ARSENIC TRIOXIDE | 10 MG / 10 ML |